Paper4175641
Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.
Yokoi S and 3 others. Arch Neurol, 1968. Cited by 121 papers, by iCite.
Cite this record
ConductScience Library. Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases. Papers, record 4175641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4175641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cerebral Cortex | Major topic |
| Cytoplasmic Granules | Major topic |
| Epilepsy | Major topic |
| Myoclonus | Major topic |
| Adolescent | |
| Adult | |
| Amylases | |
| Carbohydrates | |
| Chemical Phenomena | |
| Chemistry | |
| Chromatography, Thin Layer | |
| Glucose | |
| Glycogen Storage Disease | |
| Histocytochemistry | |
| Humans | |
| Iodine | |
| Microscopy, Electron | |
| Nerve Degeneration | |
| Nerve Tissue Proteins | |
| Polymers | |
| Spectrophotometry | |
| Spectrum Analysis | |
| Staining and Labeling |
Source PubMed
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41465357 | Adeno-Associated Virus-Based Gene Therapy for Lafora Disease in Epm2b-Deficient Mice. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465357 | PubMed |
| 41169091 | Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genes. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/41169091 | PubMed |
| 39301689 | Neuromuscular junction dysfunction in Lafora disease. | Dis Model Mech | 2024 | https://conductscience.org/library/papers/39301689 | PubMed |
| 38796707 | Gene therapy for Lafora disease in the Epm2a-/- mouse model. | Mol Ther | 2024 | https://conductscience.org/library/papers/38796707 | PubMed |
| 38341935 | Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice. | Epilepsy Res | 2024 | https://conductscience.org/library/papers/38341935 | PubMed |
| 35804532 | Lafora Disease and Alpha-Synucleinopathy in Two Adult Free-Ranging Moose (Alces alces) Presenting with Signs of Blindness and Circling. | Animals (Basel) | 2022 | https://conductscience.org/library/papers/35804532 | PubMed |
| 34069559 | Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34069559 | PubMed |
| 32660096 | Starch and Glycogen Analyses: Methods and Techniques. | Biomolecules | 2020 | https://conductscience.org/library/papers/32660096 | PubMed |
| 32475552 | Polyglucosan body structure in Lafora disease. | Carbohydr Polym | 2020 | https://conductscience.org/library/papers/32475552 | PubMed |
| 31667805 | Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future. | Adv Neurobiol | 2019 | https://conductscience.org/library/papers/31667805 | PubMed |
| 31353261 | Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion. | Cell Metab | 2019 | https://conductscience.org/library/papers/31353261 | PubMed |
| 31329461 | Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease. | Mol Pharm | 2019 | https://conductscience.org/library/papers/31329461 | PubMed |
| 29483193 | Lafora disease offers a unique window into neuronal glycogen metabolism. | J Biol Chem | 2018 | https://conductscience.org/library/papers/29483193 | PubMed |
| 28800070 | Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28800070 | PubMed |
| 26231210 | Mechanistic Insights into Glucan Phosphatase Activity against Polyglucan Substrates. | J Biol Chem | 2015 | https://conductscience.org/library/papers/26231210 | PubMed |
| 25699013 | Changing shapes of glycogen-autophagy nexus in neurons: perspective from a rare epilepsy. | Front Neurol | 2015 | https://conductscience.org/library/papers/25699013 | PubMed |
| 25544560 | Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease. | Mol Cell | 2015 | https://conductscience.org/library/papers/25544560 | PubMed |
| 25309313 | Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole. | Front Neurosci | 2014 | https://conductscience.org/library/papers/25309313 | PubMed |
| 24914213 | Protein degradation and quality control in cells from laforin and malin knockout mice. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24914213 | PubMed |
| 24472629 | Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease. | Mol Brain | 2014 | https://conductscience.org/library/papers/24472629 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4175641
GET https://conductscience.org/api/papers/v1/4175641/cited_by?page=2